Effectiveness of DPA in comparison to DHA in lowering plasma triglyceride levels and other cardiovascular risk factors

A randomised trial to evaluate the effects of DPA supplementation in the treatment of hypertriglyceridemia to reduce the risk of cardiovascular disease

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000641695

Enrollment

Registered

2005-10-14

Start date

2005-08-08

Completion date

2005-08-26

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The intervention is a dietary supplementation of docosapentaenoic acid (DPA) in comparison to docosahexaenoic acid (DHA) for 6 weeks duration in hypertriglyceridemic subjects to assess the efficacy of triglyceride lowering effect.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Subjects with hypertriglyceridemia.

Exclusion criteria

No exclusion criteria

Outcome results